Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
AI
Tech
Science

Celltrion
Biotech
Topics

Advertisement

Advertisement

Celltrion

Share

Top Latest Popular

Friday

Celltrion nears annual target on biosimilar surge Korea JoongAng Daily 00:07 Fri, 06 Nov

Thursday

Celltrion brings 3 new biosimilars to Brazil, taking portfolio to 10 Korea Biomedical Review 02:16 Thu, 05 Nov

Wednesday

Celltrion unveils promising results for four-target obesity drug The Korea Herald 05:06 Wed, 04 Nov

Advertisement

Advertisement

Celltrion's 4-hormone obesity drug beats Lilly's retatrutide on weight loss in rat study Korea Biomedical Review 01:06 Wed, 04 Nov

Monday

Celltrion Pharm adds lower-priced safety syringe to Yuflyma lineup Korea Biomedical Review 07:27 Mon, 02 Nov

In the last month

FTC fines Celltrion 630 million won over unfair test kit subcontracting Korea JoongAng Daily 05:11 Thu, 29 Oct

Watchdog to fine Celltrion 630m over unfair subcontracting practices The Korea Herald 05:00 Thu, 29 Oct

Watchdog to fine Celltrion $469,000 over unfair subcontracting practices The Korea Times 03:44 Thu, 29 Oct

Celltrion Q3 operating profit jumps 74% on strong sales of high-margin biosimilars Korea Biomedical Review 01:06 Tue, 27 Oct

Celltrion's Omlyclo, Avtozma displace originators in US formulary deals Korea Biomedical Review 00:41 Mon, 26 Oct

Celltrion and Kaigene sign $580m licence deal for KG013 Hospital Management 10:44 Fri, 23 Oct

Kaigene Enters into Exclusive Global Licensing Agreement with Celltrion for Next-Generation Anti-April Antibody KG013 PR Newswire (Press Release) 14:02 Thu, 22 Oct

Celltrion secures three autoimmune drug candidates through deal with U.S. firm Kaigene Asia Today 07:20 Thu, 22 Oct

Celltrion deepens bet on US biotech Kaigene with 3rd autoimmune drug candidate Korea Biomedical Review 05:38 Thu, 22 Oct

Celltrion to highlight Remsima SC clinical data at UEG Week 2026 The Korea Herald 03:28 Thu, 15 Oct

Advertisement

Celltrion to present real-world Remsima SC data at UEG Week 2026 Korea Biomedical Review 02:35 Thu, 15 Oct

Celltrion to Spotlight Subcutaneous (SC) Infliximab (Remsima™ SC) and Broader IBD Portfolio at Ueg Week 2026 Business Wire (Press Release) 01:16 Thu, 15 Oct

Celltrion Launches Omalizumab Biosimilar in the United States JD Supra 23:54 Wed, 14 Oct

Celltrion nears additional contract with major U.S. PBM Asia Today 05:20 Wed, 14 Oct

Spotlight On: Herceptin® (trastuzumab) / Ogivri® (trastuzumab-dkst) / Herzuma® (trastuzumab-pkrb) / Ontruzant® (trastuzumab-dttb)... JD Supra 17:33 Tue, 13 Oct

Celltrion's operating profit jumps 69% as revenue rises 46%, but ensuring profitability remains key Asia Today 01:42 Tue, 13 Oct

Spotlight On: Biosimilar Litigations - October 2026 JD Supra 22:31 Mon, 12 Oct

Celltrion Q3 operating profit tops W500 bil. mark for 1st time The Korea Times 07:18 Mon, 12 Oct

Celltrion posts first W500b quarterly operating profit The Korea Herald 03:29 Mon, 12 Oct

Celltrion's profit outpaces sales growth as newer biosimilars gain ground Korea Biomedical Review 01:35 Mon, 12 Oct

Celltrion to Present New Analyses of Zymfentra® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026 PR Newswire (Press Release) 18:02 Sun, 11 Oct

Advertisement

Advertisement

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna